Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Unraveling the Specialty of Picking Your Ideal Travel Objective - 2SpaceX launches Italian Earth-observing satellite to orbit on the 1st mission of 2026 (video)
- 3Exemplary Fragrances: A Manual for Notorious Scents
- 4How does spider venom damage human cells? Researchers uncover the killer mechanism of recluse spider toxin
- 5Grasping the Qualifications Among Separation and Dissolution
- The most effective method to Amplify Your Opportunity for growth in a Web-based Degree Program
- A Gastronomic Experience in Healthy Enjoyments: A Survey of \Nutritious and Tasty\ Solid Cooking Recipe Book
- Vote In favor of Your Favored Kind Of Vegetable
- The Minimized Passage Horse: Reconsidering a Symbol for the Cutting edge Period
- Was This Driver Simply Having A great time Or Behaving Like An Ass?
- Find the Mysteries of Powerful Using time productively: Augmenting Efficiency and Proficiency
- Lockheed Martin opens new hypersonic weapons facility
- Family Holiday spots
- Parents who delay baby's first vaccines also likely to skip measles shots
